Dihydroartemisinin inhibits cell proliferation by induced G1 arrest and apoptosis in human nasopharyngealcarcinoma cells

被引：14

作者：

Huang, Zhenhe ^{[1
]}

Huang, Xueqin ^{[2
]}

Jiang, Donghui ^{[4
]}

Zhang, Yuefei ^{[3
,4
]}

Huang, Bo ^{[4
]}

Luo, Guoqing ^{[3
,4
]}

机构：

[1] Ganzhou Peoples Hosp, Dept Otolaryngol, Ganzhou 341000, Jiangxi, Peoples R China

[2] Guangdong Med Coll, Clin Coll 2, Dongguan, Guangdong, Peoples R China

[3] Guangdong Med Coll, Dept Otolaryngol, Zhanjiang 524023, Guangdong, Peoples R China

[4] Guangdong Med Coll, Affiliated Hosp 1, Zhanjiang 524023, Guangdong, Peoples R China

来源：

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS | 2016年 / 12卷 / 01期

关键词：

Cancer; dihydroartemisinin; nasopharyngeal carcinoma; natural compound; EPSTEIN-BARR-VIRUS; GROWTH-INHIBITION; CARCINOMA-CELLS; CYCLE ARREST; CANCER; ARTEMISININ; ARTESUNATE; EXPRESSION;

D O I：

10.4103/0973-1482.151855

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Context: Dihydroartemisinin (DHA) exhibits anticancer activity in a number of human cancer cells. However, it is still unknown whether DHA has anticancer effect on nasopharyngeal cancer (NPC) cells. Aims: To investigate the anticancer activity of DHA on CNE-2 cells. Materials and Methods: Cell cycleand invasion assay were used to detect the effect of DHA on CNE-2 cells. Protein molecular differences were examined by Western blot. Results: DHA strongly inhibited cell proliferation by induced cell cycle G1 arrest and apoptosis in CNE-2 cells. In addition, cell motility, invasion, and colony formation were suppressed by DHA. Conclusions: DHA shows significant anticancer effects on human NPC cells, and may be a preventive and therapeutic agent against NPC.

引用

页码：244 / 247

页数：4

共 27 条

[1] The enigmatic epidemiology of nasopharyngeal carcinoma [J].

Chang, Ellen T. ;

Adami, Hans-Olov .

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (10) :1765-1777

[2] Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest and inactivation of nuclear factor-κB [J].

Chen, Hua ;

Sun, Bei ;

Wang, Shuangjia ;

Pan, Shangha ;

Gao, Yue ;

Bai, Xuewei ;

Xue, Dongbo .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (06) :897-903

[3] Nasopharyngeal carcinoma: molecular biomarker discovery and progress [J].

Cho, William Chi-shing .

MOLECULAR CANCER, 2007, 6 (1)

[4]

Dell' Eva R, 2004, BIOCHEM PHARMACOL, V68, P2359

[5] mRNA expression profiles for the response of human tumor cell lines to the antimalarial drugs artesunate, arteether, and artemether [J].

Efferth, T ;

Olbrich, A ;

Bauer, R .

BIOCHEMICAL PHARMACOLOGY, 2002, 64 (04) :617-623

[6]

Efferth T, 2001, INT J ONCOL, V18, P767

[7] Interruption of the MEK/ERK signaling cascade promotes dihydroartemisinin-induced apoptosis in vitro and in vivo [J].

Gao, Ning ;

Budhraja, Amit ;

Cheng, Senping ;

Liu, E-Hu ;

Huang, Cheng ;

Chen, Jieping ;

Yang, Zailin ;

Chen, Deying ;

Zhang, Zhuo ;

Shi, Xianglin .

APOPTOSIS, 2011, 16 (05) :511-523

[8]

Huang Zhenhe, 2013, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V27, P717

[9] Anti-tumor effects of dihydroartemisinin on human osteosarcoma [J].

Ji, Ye ;

Zhang, Yi-Cai ;

Pei, Liu-Bao ;

Shi, Li-Li ;

Yan, Jing-Long ;

Ma, Xue-Hua .

MOLECULAR AND CELLULAR BIOCHEMISTRY, 2011, 351 (1-2) :99-108

[10] Dihydroartemisinin is an inhibitor of ovarian cancer cell growth [J].

Jiao, Yang ;

Ge, Chun-min ;

Meng, Qing-hui ;

Cao, Jian-ping ;

Tong, Jian ;

Fan, Sai-jun .

ACTA PHARMACOLOGICA SINICA, 2007, 28 (07) :1045-1056

← 1 2 3 →